Ganymede Bio
Latest round
- Series A
Last raised
- Jul 2022
Total raised
- $15M
Investors
- 1
About Ganymede Bio
Founded in 2022 and based in California, US, Ganymede Bio, Inc. provides cloud infrastructure for the life sciences and manufacturing industries. Benson Lee and Nathan Clark are the co-founders of the company. In December 2022, Ganymede Bio, Inc. The company offers a platform for whole-lab automation and data integration that enables users to write, test, and run integrations between anything in a lab. The firm provides a declarative library of high-level automation tools and bioinformatic functions, as well as the ability to virtualize integrations that can be developed using an internal scheme, inherit structure from apps, access open public databases, use ontologies, and more. Ganymede generates a UI for mapping data that acts as tables for engineers' integrations. The platform also includes biologically aware types and connectors, the ability to store everything for auditing and debugging experiments, the ability to automate ingestion, self-service human-in-the-loop tooling, ML-powered data cleaning, and other features.
Who invested in Ganymede Bio
1 investor across 1 round
See all investors in Ganymede Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 25, 2022
Amount
$15M
Investors
Questions about Ganymede Bio
Who invested in Ganymede Bio?
Ganymede Bio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ganymede Bio raised?
Ganymede Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ganymede Bio last raise money?
Ganymede Bio's most recent round on record is a Series A, in Jul 2022.
What does Ganymede Bio do?
Founded in 2022 and based in California, US, Ganymede Bio, Inc.
Where is Ganymede Bio headquartered?
Ganymede Bio is headquartered in Palo Alto, US.
Which VCs invest in companies like Ganymede Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Ganymede Bio's stage. Their profiles are linked below.
VCs backing software startups at Series A
Raising like Ganymede Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.